SURG-29. Amphicrine brain metastasis from prostate cancer and the role of surgical intervention: an illustrative case

Abstract Prostate cancer is the second most commonly diagnosed cancer in men worldwide, particularly in men 65 years and older. It has a high proclivity for metastasis to the bones, lymph nodes, and liver. Contrary to breast or lung cancer, prostate cancer (PC) metastasis to brain parenchyma is exceedingly rare, accounting for fewer than 1% of all brain metastases. Histologic classifications of PC metastasis subtypes continue to be refined in the literature, and the role of surgical management of PC metastases to the brain is evolving. There is a relative paucity of data regarding treatment recommendations for aggressive PC subtypes such as amphicrine carcinoma, which has both adenocarcinoma and neuroendocrine differentiation. This case report represents a rare instance of an intraparenchymal amphicrine PC metastasis. A 77-year-old right-handed man presented to the emergency department with transient aphasia, initially concerning for stroke. MRI revealed a 2 cm enhancing mass of the left middle temporal gyrus, with high-grade glioma leading the differential diagnosis based on imaging characteristics. His past medical history was notable for prostate adenocarcinoma metastatic to bone, lymph nodes, and liver. He underwent an awake craniotomy for gross total resection and discharged two days later. Final pathology revealed an amphicrine PC brain metastasis. He was treated with adjuvant gamma knife radiation, then resumed systemic chemotherapy and ADT. At 3 months, his functional status remained stable, and MRI showed no recurrence. Prostate cancer very rarely metastasizes to brain parenchyma. However, in a patient with prostate cancer and known metastases to bones or visceral organs, the differential for a new brain mass should include prostate metastasis. In these cases, surgical intervention must be considered in conjunction with radiotherapy, with particular attention to high grade subtypes of PC.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-11-01
DOI
https://doi.org/10.1093/neuonc/noaf201.1586
Primary Topic
Brain Metastases and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SURG-29. Amphicrine brain metastasis from prostate cancer and the role of surgical intervention: an illustrative case

Jacob Ruzevick, Samuel Emerson, Dominic Nistal, Rose Wang et al.
Neuro-Oncology
Brain Metastases and Treatment
article

SURG-29. Amphicrine brain metastasis from prostate cancer and the role of surgical intervention: an illustrative case

Jacob Ruzevick, Samuel Emerson, Dominic Nistal, Rose Wang, Sampath Narayanan, Jack D. Sedwick, Eric Lassiter, Manuel Ferreira, Jessica Eaton, Zack Abecassis, Thomas Hanks, Ivan W. Brown, Kyly Hiatt, R Berrigan, Margot Kelly-Hendrick, Kaityln Hartyl
article en

Abstract

Abstract Prostate cancer is the second most commonly diagnosed cancer in men worldwide, particularly in men 65 years and older. It has a high proclivity for metastasis to the bones, lymph nodes, and liver. Contrary to breast or lung cancer, prostate cancer (PC) metastasis to brain parenchyma is exceedingly rare, accounting for fewer than 1% of all brain metastases. Histologic classifications of PC metastasis subtypes continue to be refined in the literature, and the role of surgical management of PC metastases to the brain is evolving. There is a relative paucity of data regarding treatment recommendations for aggressive PC subtypes such as amphicrine carcinoma, which has both adenocarcinoma and neuroendocrine differentiation. This case report represents a rare instance of an intraparenchymal amphicrine PC metastasis. A 77-year-old right-handed man presented to the emergency department with transient aphasia, initially concerning for stroke. MRI revealed a 2 cm enhancing mass of the left middle temporal gyrus, with high-grade glioma leading the differential diagnosis based on imaging characteristics. His past medical history was notable for prostate adenocarcinoma metastatic to bone, lymph nodes, and liver. He underwent an awake craniotomy for gross total resection and discharged two days later. Final pathology revealed an amphicrine PC brain metastasis. He was treated with adjuvant gamma knife radiation, then resumed systemic chemotherapy and ADT. At 3 months, his functional status remained stable, and MRI showed no recurrence. Prostate cancer very rarely metastasizes to brain parenchyma. However, in a patient with prostate cancer and known metastases to bones or visceral organs, the differential for a new brain mass should include prostate metastasis. In these cases, surgical intervention must be considered in conjunction with radiotherapy, with particular attention to high grade subtypes of PC.

Neuro-OncologyVol. 27(Supplement_5)
University of Washington (US), Seattle University (US)
Openalex Percentile: Top 51%
Brain Metastases and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.